This announcement is a separate document:
海通证券股份有限公司关于上海南方模式生物科技股份有限公司2024年度持续督导半年度跟踪报告
Haitong Securities Co., Ltd.\'s 2024 semi-annual follow-up report on the continuous supervision of Shanghai Southern Model Biotechnology Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.